FDA Approves Moderna's mRNA Flu Vaccine for Upcoming Season

The U.S. Food and Drug Administration (FDA) has granted approval for Moderna's mRNA vaccine against influenza, marking the first mRNA-based flu vaccine. This development means the new shot will be available for the upcoming flu season, with a study indicating a 27% reduction in flu cases for recipients compared to other flu vaccines.